SCHEMBL13047065

SCHEMBL13047065

CSc1cccc(Oc2ccc(C)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 3/20 0.49
SLC6A4 P31645 1/20 0.45
TEAD4 Q15561 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
MITF O75030 1/20 0.42
GAA P10253 1/20 0.42
GFER P55789 1/20 0.42
NLRP1 Q9C000 1/20 0.42
NOD2 Q9HC29 1/20 0.42
FFAR4 Q5NUL3 1/20 0.40
SLC5A2 P31639 1/20 0.40
AR P10275 2/20 0.39
FFAR1 O14842 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28637158 0.88 CYP1A1 (0.42) TDP1ALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL19490623 0.86 LTA4H (0.50) HTTALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL83816 0.82 TDP1 (0.61) HTTTDP1L3MBTL1ALDH1A1TEAD4
SCHEMBL407203 0.80 TEAD4 (0.54) HTTTDP1ALDH1A1SLC6A4TEAD4
SCHEMBL3757600 0.80 CYP19A1 (0.47) ALDH1A1SLC6A4SMN1; SMN2MAPTMEN1
SCHEMBL9505086 0.80 TTR (0.42) HTTALDH1A1SLC6A4SMN1; SMN2MAPT
SCHEMBL2706825 0.78 SRD5A2 (0.56) SMN1; SMN2POLB
SCHEMBL15085780 0.78 SMN1; SMN2 (0.60) HTTTDP1L3MBTL1ALDH1A1TEAD4
SCHEMBL822034 0.78 ALDH1A1 (0.74) HTTTDP1L3MBTL1ALDH1A1TEAD4
SCHEMBL30195024 0.78 ALDH1A1 (0.74) HTTTDP1L3MBTL1ALDH1A1TEAD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R HTT 4501/4885TDP1 4215/4885L3MBTL1 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.